Extendicare (TSE:EXE – Free Report) had its price objective raised by TD Securities from C$9.50 to C$10.50 in a research note published on Thursday morning,BayStreet.CA reports.
Separately, Royal Bank of Canada boosted their price target on shares of Extendicare from C$8.50 to C$9.50 in a research report on Monday, August 19th.
View Our Latest Analysis on Extendicare
Extendicare Price Performance
Extendicare (TSE:EXE – Get Free Report) last announced its quarterly earnings results on Monday, August 12th. The company reported C$0.29 earnings per share for the quarter. Extendicare had a net margin of 4.28% and a return on equity of 60.00%. The company had revenue of C$348.48 million for the quarter, compared to analysts’ expectations of C$360.20 million. On average, equities analysts forecast that Extendicare will post 0.6134729 EPS for the current year.
Extendicare Dividend Announcement
The firm also recently declared a monthly dividend, which will be paid on Friday, November 15th. Investors of record on Thursday, October 31st will be given a $0.04 dividend. This represents a $0.48 annualized dividend and a yield of 4.75%. The ex-dividend date is Thursday, October 31st. Extendicare’s dividend payout ratio is presently 70.59%.
About Extendicare
Extendicare Inc, through its subsidiaries, provides care and services for seniors in Canada. The company offers long term care (LTC) services; and home health care services, such as nursing care, occupational, physical and speech therapy, and assistance with daily activities, as well as management, consulting, and other services to third parties.
Featured Stories
- Five stocks we like better than Extendicare
- How to Invest in Blue Chip Stocks
- Top-Performing Non-Leveraged ETFs This Year
- Top Biotech Stocks: Exploring Innovation Opportunities
- Rivian’s Wild Ride: Is the Dip a Buying Opportunity?
- What is a Bond Market Holiday? How to Invest and Trade
- Freshworks Stock Soars 50% – Is This the Perfect Entry Point?
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.